» Articles » PMID: 11936514

Interpreting Thresholds for a Clinically Significant Change in Health Status in Asthma and COPD

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 2002 Apr 9
PMID 11936514
Citations 170
Authors
Affiliations
Soon will be listed here.
Abstract

Health status (or Health-Related Quality of Life) measurement is an established method for assessing the overall efficacy of treatments for asthma and chronic obstructive pulmonary disease (COPD). Such measurements can indicate the potential clinical significance of a treatment's effect. This paper is concerned with methods of estimating the threshold of clinical significance for three widely used health status questionnaires for asthma and COPD: the Asthma Quality of Life Questionnaire, Chronic Respiratory Questionnaire and St George's Respiratory Questionnaire. It discusses the methodology used to obtain such estimates and shows that the estimates appear to be fairly reliable; ie. for a given questionnaire, similar estimates may be obtained in different studies. These empirically derived thresholds are all mean estimates with confidence intervals around them. The presence of these confidence intervals affects the way in which the thresholds may be used to draw inferences concerning the clinical relevance of clinical trial results. A new system of judging the magnitude of clinically significant results is proposed. Finally, an attempt is made to translate these thresholds into scenarios that illustrate what a clinically significant change with treatment may mean to an individual patient.

Citing Articles

Feasibility, Usability, and Pilot Efficacy Study of a Software-Enabled, Virtual Pulmonary Rehabilitation with Remote Therapeutic Monitoring.

Flynn S, Mosher C, Cornelison S, Rao E, Metzler K, Pu W Int J Chron Obstruct Pulmon Dis. 2025; 20:231-241.

PMID: 39906676 PMC: 11792638. DOI: 10.2147/COPD.S484558.


How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?.

Kerwin E, Jones P, Bjermer L, Maltais F, Boucot I, Naya I Chron Respir Dis. 2023; 20:14799731231202257.

PMID: 37800633 PMC: 10903204. DOI: 10.1177/14799731231202257.


Rituximab Monotherapy Is Effective as First-Line Treatment for Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in CVID Patients.

Tessarin G, Baronio M, Gazzurelli L, Rossi S, Chiarini M, Moratto D J Clin Immunol. 2023; 43(8):2091-2103.

PMID: 37755605 PMC: 10661825. DOI: 10.1007/s10875-023-01587-4.


The Impact of Chronic Pulmonary Aspergillosis Co-infection on the Health-Related Quality of Life of Patients with Pulmonary Tuberculosis in Uganda.

Namusobya M, Bongomin F, Mukisa J, Batte C, Olwit W, Rhein J Mycopathologia. 2023; 188(5):713-720.

PMID: 37195546 DOI: 10.1007/s11046-023-00741-1.


Design of Lung Transplant Go (LTGO): A randomized controlled trial evaluating the efficacy of a telerehabilitation behavioral exercise intervention to improve physical activity, physical function, and blood pressure control after lung transplantation.

Vendetti M, Esther Moon S, Imes C, Hergenroeder A, Sciurba F, Lendermon E Contemp Clin Trials Commun. 2023; 33:101097.

PMID: 36911577 PMC: 9999171. DOI: 10.1016/j.conctc.2023.101097.